首页> 美国卫生研究院文献>Clinics >Efficacy of levofloxacin amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers
【2h】

Efficacy of levofloxacin amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers

机译:左氧氟沙星阿莫西林和质子泵抑制剂在巴西消化性溃疡患者中根除幽门螺杆菌的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVES:The eradication of Helicobacter (H.) pylori allows peptic ulcers in patients infected with the bacteria to be cured. Treatment with the classic triple regimen (proton pump inhibitor, amoxicillin and clarithromycin) has shown decreased efficacy due to increased bacterial resistance to clarithromycin. In our country, the eradication rate by intention to treat with this regimen is 83%. In Brazil, a commercially available regimen for bacterial eradication that uses levofloxacin and amoxicillin with lansoprazole is available; however, its efficacy is not known. Considering that such a treatment may be an alternative to the classic regimen, we aimed to verify its efficacy in H. pylori eradication.
机译:目的:根除幽门螺杆菌可以治愈感染细菌的患者的消化性溃疡。经典的三联疗法(质子泵抑制剂,阿莫西林和克拉霉素)治疗已显示出功效降低,原因是细菌对克拉霉素的耐药性增加。在我国,用这种方案治疗的根除率为83%。在巴西,有一种使用左氧氟沙星和阿莫西林与兰索拉唑联合使用的商业细菌消灭方案;但是,其功效尚不清楚。考虑到这种治疗可能是经典疗法的替代方法,我们旨在验证其在根除幽门螺杆菌中的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号